The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15397
StudyName: Eligibility Lymphoma NCT02169505
Date of export from the portal: 02.07.2020
Date of Upload / last change: 30.05.2016
License: Creative Commons BY 4.0

----

Description: 
Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT); ODM derived from: https://clinicaltrials.gov/show/NCT02169505
